Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in mri imaging of joints
CA 2393232 C · Owner: Rosen, Gerald M. · Inventors: Rosen, Gerald M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The image obtained by MR imaging of the joint of an animal including humans, is enhanced by injecting into the joint prior to the scan of an imaging enhancing amount of a nitroxyl functionalized dendrimer containing at least 6 nitroxyl terminal functional groups, e.g of Formula (I) wherein each R , independently is either a nitroxyl group of Formula (II) wherein X is an oxygen atom or two hydrogen atoms, R' is lower alkyl and R" is H or lower alkyl, or a group of Formula (III) wherein R'" is lower alkyl or a group of , Formula (IV): wherein each alkylene in Formulae (I) (III) and (IV) is a , bridging divalent alkylene group of 2-6 carbon atoms with 2-3 carbon atoms in the chain and R …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 6, 2000 and granted May 31, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 6, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 6, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.